AGP Executive Report
Last update: an hour agoCancer Care Update: A Shanxi Province Cancer Hospital study in BMC Cancer reports that adding tislelizumab (PD-1) to chemo plus bevacizumab may extend survival for recurrent cervical cancer patients. Mental Health & Oncology: A multicenter China study in Supportive Care in Cancer links worsening emotional distress over the course of neoadjuvant therapy and surgery with poorer survival in resectable non–small cell lung cancer. Infectious Disease Watch: Hong Kong’s SSM says an 82-year-old man returning from China developed Legionnaires’ disease and is in critical condition; family members report no symptoms. Biosecurity Alert: China’s Ministry of State Security warns of overseas attempts to steal genetic resources, including smuggling human blood samples and bringing in exotic pets/plant seeds without proper approvals. Regulatory/Industry: Novartis signed a deal worth up to $7.8B with China’s Abogen for mRNA-based therapies, highlighting continued big pharma interest in Chinese RNA platforms. Health Workforce/Access: China’s “Hundred Days, Ten Million Jobs” campaign held online job fairs including healthcare, drawing thousands of employers and openings.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
